Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Xencor Gets $120m Up Front F
There have been many attempts to resurrect Alzheimer's disease candidates out of trial failures, looking at different markers or stages of disease, but Alzheon Inc. believes that it has sufficient
IN VITRO DIAGNOSTICS Mergers & Acquisitions Clinical Genomics Technologies Pty. Ltd. Quest Diagnostics Inc. Enterix Inc. As part of a continued effort to focus on its Diagnostics Information Services